Inflammatory Mechanisms in Obesity and Weight Loss

Obesity is characterised by chronic, low-grade inflammation driven by adipose tissue dysfunction, immune cell infiltration and altered secretory profiles. Excess adiposity remodels adipose depots, promotes macrophage and T-cell recruitment and shifts adipokine balance towards proinflammatory mediators such as tumour necrosis factor-α and interleukin-6. This state exacerbates insulin resistance, endothelial dysfunction and dyslipidaemia, thereby increasing the risk of type 2 diabetes, cardiovascular disease and certain cancers. Weight loss—whether achieved by caloric restriction, pharmacotherapy or bariatric surgery—initiates a cascade of metabolic improvements. Early reductions in insulin levels, free fatty acids and lipid intermediates precede dampening of proinflammatory cytokine release. Subsequent alterations in immune cell phenotypes, notably reduced Th1 and Th17 activity and a rebound in regulatory T-cell populations, contribute to the resolution of systemic inflammation. Improvements in endothelial glycocalyx integrity, adipokine ratios (for example adiponectin to leptin) and markers of oxidative stress underpin vascular protection and metabolic homeostasis. Understanding the temporal sequence and mechanistic links between metabolic shift and inflammatory resolution is essential to optimising interventions and predicting long-term outcomes.

Research from Nature Portfolio

A prospective study in patients undergoing bariatric and metabolic surgery revealed that metabolic parameters improve ahead of systemic inflammatory markers. Within three months of surgery, indices such as insulin concentration, HOMA-IR and lipid profiles declined significantly, whereas high-sensitivity C-reactive protein, tumour necrosis factor-α, interleukin-1β, interleukin-6, interleukin-8 and signature Th1 and Th17 cytokines only fell after six months. Correlation analyses indicated that reductions in body mass index, fat mass and triglycerides closely tracked later declines in inflammatory cytokines, suggesting that metabolic restoration is a prerequisite for the subsequent resolution of low-grade inflammation. These findings clarify the temporality of metabolic and immune remodelling and support the concept that early metabolic shifts trigger downstream anti-inflammatory processes.

Inflammatory Mechanisms in Obesity and Weight Loss publication trend

The graph below shows the total number of articles in inflammatory mechanisms in obesity and weight loss across all publications each year (not limited to Nature Index journals).

Technical terms

Adipokines: Bioactive proteins secreted by adipose tissue that regulate metabolic and inflammatory processes.

Cytokines: Small signalling proteins released by immune cells that modulate inflammation and cell communication.

C-reactive protein (CRP): An acute-phase protein whose circulating level rises in response to systemic inflammation.

HOMA-IR: Homeostatic Model Assessment of Insulin Resistance, an index derived from fasting insulin and glucose to estimate insulin sensitivity.

Bariatric surgery: Surgical procedures, including gastric bypass and sleeve gastrectomy, designed to induce significant and sustained weight loss.

References

1. Serum levels of Vanin-2 increase with obesity in relation to inflammation of adipose tissue and may be a predictor of bariatric surgery outcomes. Frontiers in Nutrition (2023).
2. Roux-en-Y Gastric Bypass Improves Adiponectin to Leptin Ratio and Inflammatory Profile in Severely Obese Women with and without Metabolic Syndrome: A Randomized Controlled Trial. Nutrients (2023).
3. Metabolic shift precedes the resolution of inflammation in a cohort of patients undergoing bariatric and metabolic surgery. Scientific Reports (2021).
4. Interplay between the Adaptive Immune System and Insulin Resistance in Weight Loss Induced by Bariatric Surgery. Oxidative Medicine and Cellular Longevity (2019).